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Abstract
Background: The success of Enterococcus faecium and E. faecalis evolving as multi-resistant nosocomial pathogens
is associated with their ability to acquire and share adaptive traits, including antimicrobial resistance genes encoded
by mobile genetic elements (MGEs). Here, we investigate this mobilome in successful hospital associated
genetic lineages, E. faecium sequence type (ST)17 (n=10) and ST78 (n=10), E. faecalis ST6 (n=10) and ST40
(n=10) by DNA microarray analyses.
Results: The hybridization patterns of 272 representative targets including plasmid backbones (n=85), transposable
elements (n=85), resistance determinants (n=67), prophages (n=29) and clustered regularly interspaced short palindromic
repeats (CRISPR)-cas sequences (n=6) separated the strains according to species, and for E. faecalis also according
to STs. RCR-, Rep_3-, RepA_N- and Inc18-family plasmids were highly prevalent and with the exception of Rep_3,
evenly distributed between the species. There was a considerable difference in the replicon profile, with rep17/pRUM, rep2/
pRE25, rep14/EFNP1 and rep20/pLG1 dominating in E. faecium and rep9/pCF10, rep2/pRE25 and rep7 in E. faecalis strains. We observed
an overall high correlation between the presence and absence of genes coding for resistance towards antibiotics, metals,
biocides and their corresponding MGEs as well as their phenotypic antimicrobial susceptibility pattern. Although most IS
families were represented in both E. faecalis and E. faecium, specific IS elements within these families were distributed in
only one species. The prevalence of IS256-, IS3-, ISL3-, IS200/IS605-, IS110-, IS982- and IS4-transposases was significantly
higher in E. faecium than E. faecalis, and that of IS110-, IS982- and IS1182-transposases in E. faecalis ST6 compared to ST40.
Notably, the transposases of IS981, ISEfm1 and IS1678 that have only been reported in few enterococcal isolates were well
represented in the E. faecium strains. E. faecalis ST40 strains harboured possible functional CRISPR-Cas systems, and still
resistance and prophage sequences were generally well represented.
Conclusions: The targeted MGEs were highly prevalent among the selected STs, underlining their potential importance
in the evolution of hospital-adapted lineages of enterococci. Although the propensity of inter-species horizontal
gene transfer (HGT) must be emphasized, the considerable species-specificity of these MGEs indicates a
separate vertical evolution of MGEs within each species, and for E. faecalis within each ST.
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Background
The emergence of E. faecalis and E. faecium as leading
hospital pathogens worldwide has been associated with
their promiscuous nature in acquiring new genetic ele-
ments through HGT. HGT facilitates the adaptation of
specific genetic lineages to the hospital environment by
enabling acquisition of antimicrobial resistance, bacteri-
ocin and virulence determinants that provide selective
advantages and promote gastrointestinal colonization
[1-8]. Molecular epidemiological studies using multi-
locus sequence typing (MLST) and eBURST analysis
identified a worldwide polyclonal cluster of hospital
adapted E. faecium clones, termed at that time clonal
complex (CC) 17, which contained sequence type (ST) 17
as well as its possible descendants; single locus variants
ST16, ST78, ST63, ST64 and ST174 [9,10]. However, re-
cent Bayesian-based population genetic modelling com-
paring whole genome sequences, suggests the existence of
two clades of E. faecium strains (clade A and B), where
clade A (A1) includes E. faecium associated with human
infections from CC17 as opposed to clade B that contains
strains of non-hospital human origin [6,11,12]. E. faecalis,
in general, seem to be less origin- and/or host-restricted
as dominant clones are shared between hospitals and the
community although some CCs, including CC2, CC40
and CC87 show clear over-representation in hospital-
associated infections [13].
Whole genome sequencing, comparative genome analysis
and molecular epidemiological studies have provided im-
portant information about the content and distribution of
MGEs in E. faecalis and E. faecium [11,14-21]. Plasmids,
transposons, and prophages all contribute to the plasticity
of enterococcal genomes [2,22] and clinical E. faecium
strains have twice as many genes associated with MGEs
as compared to non-clinical strains [16]. Sequence
variability, presence of mosaic structures of plasmids
combining modules from various origin and chimeric
plasmids indicates a high genetic diversity of enterococcal
plasmids [21,23-26]. Further, plasmid-mediated intraspecies
chromosome-to-chromosome transfer of large DNA seg-
ments has been documented for both E. faecalis [3] and E.
faecium [27]. In hospital-associated enterococci, plasmid
stabilizing toxin-antitoxin (TA) systems, including Axe-Txe
and ω-ε-ζ, are prevalent [26,28,29]. Notably, such TA-
systems are increasingly considered as targets for devel-
opment of new antimicrobial agents against multidrug
resistant pathogens [30-34]. The impact of prophages
on enterococcal diversity is less understood, but whole
genome sequencing of E. faecium strains identified pro-
phages as a prominent source of genome diversity
[6,15,16].
Our epidemiological knowledge of MGEs in enterococci is
limited and have mainly been based on the characterization
of a restricted number of strains. The population structure
of the examined strains have not been well characterized
and their selection has been from a very broad range of
origins and/or biased by certain characteristics such as
specific antibiotic resistance mechanisms. Thus, we still
have a considerable gap in our knowledge concerning
the presence and relative distribution of known MGEs
in different clinically relevant genetic lineages of en-
terococci and the potential role of these MGEs in the
ecological dominance of enterococcal lineages in hospi-
tals. In order to provide new insight in the complex
mobile gene pool of E. faecalis and E. faecium (the
mobilome [35]), we developed a DNA microarray with
markers of enterococcal mobile genetic elements (including
antimicrobial resistance genes) and CRISPR-cas ele-
ments identified so far. The arrays were hybridized with
single strain genomic DNA of 40 enterococcal hospital as-
sociated strains. The mobilome profiles distinguished en-
terococci at species and subspecies level. The observed
homogeneous hybridization pattern between E. faecium
STs is in accordance with an evolutionary relatedness of
ST17 and ST78 [6].
Methods
Bacterial strains
A total of 40 human E. faecium and E. faecalis strains
representing four highly prevalent and clinical relevant
STs; E. faecium (ST17, n = 10; ST78, n = 10) and E. fae-
calis (ST6, n = 10; ST40, n = 10), were selected. Relevant
strain characteristics are given in Table 1. Briefly, the
strains originated from nine European countries
(Denmark, Germany, Italy, Norway, Poland, Portugal,
Spain, Sweden, and The Netherlands) and were isolated
between 1992 and 2009. With the exception of one fecal
strain, all were clinical strains and some have been asso-
ciated with hospital outbreaks. The fully sequenced E.
faecalis V583 [36] was included as a control to monitor
the hybridization quality.
DNA isolation, hybridization and data acquisition
Single strain genomic DNA for microarray hybridization
and PCR was extracted using E.Z.N.A Bacterial DNA kit
(Omega Bio-Tek Inc., Norcross, GA) with the following
modifications: cell walls were digested with 7 μg/μL lyso-
zyme and 0.5 U/μL mutanolysin for 20 min at 30°C, and
DNA was eluted with ddH2O. For hybridization, DNA
was broken down to 100–600 bp fragments by 1 min
sonication at 2 μm amplitude. Genomic DNA (2 μg) was
fluorescent labeled using the Kreatech labeling kit with
ULS-Cy5 according to the manufacturer’s instructions
(Kreatech Biotechnologies, Amsterdam, The Netherlands),
and degree of labeling (DoL) was calculated by measuring
absorbance at 260 and 650 nm using a Nanodrop spectro-
photometer. Hybridization of 4X2K CustomArrays were
performed as described by the manufacturer (CustomArray
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Table 1 Clinical enterococcal strains used for hybridization
No ST/CC Name Source Country Year Reference
E. faecium
1 17/17 U0229 Blood NLD 1995 [37]
2 17/17 TUH2-18 Urine NOR 1996 [38,39]
3 17/17 U0218 Blood NLD 1997 [37]
4 17/17 E1463 Blood ESP 1998 [40]
5 17/17 O2T878 Blood SWE 2002 [41]
6 17/17 NIZP292/02 Wound POL 2002 [42]
7 17/17 U0106 Blood NLD 2004 [37]
8 17/17 VRE-10 Blood DEN 2005 [43]
9 17/17 UW6900 Blood GER 2006 [44,45]
10 17/17 VRE-84 VA DEN 2008 [43]
11 78/17 E1644 Urine GER 2002 [46]
12 78/17 U0262 Blood NLD 2004 [37]
13 78/17 U0367 Blood NLD 2004 [37]
14 78/17 E2603 Blood NLD 2005 [37]
15 78/17 E4076 Blood NLD 2006 [37]
16 78/17 UW6847 Blood GER 2006 [45]
17 78/17 UW6880 Blood GER 2006 [45,47]
18 78/17 HPH3 Urine PRT 2007 [47]
19 78/17 VRE-106 Urine DEN 2008 [43]
20 78/17 VRE0673 Feces SWE 2008 [48]
E. faecalis
21 6/2 229710 Urine PRT 1992 [49]
22 6/2 2724 Blood ITA 1993 [50]
23 6/2 217691 Blood PRT 1996 [50,51]
24 6/2 E1828 Blood ESP 2001 [52]
25 6/2 E3450 Blood NLD 2006 [13]
26 6/2 UW7001 Blood GER 2006 [13]
27 6/2 340/07 Blood POL 2007 [13]
28 6/2 1665/07 Blood DEN 2007 [13]
29 6/2 VRE-115 Blood DEN 2008 [43]
30 6/2 3962/09 Blood NLD 2009 [13]
31 40/40 435/96 Urine POL 1996 [53,54]
32 40/40 UW1833 Urine GER 1998 This study, [53,54]
33 40/40 7239/99 Urine POL 1999 [53-55]
34 40/40 HC24 Blood ESP 2001 [52-54]
35 40/40 457/04 Urine POL 2004 [53-55]
36 40/40 UW5744 Urine GER 2004 This study, [53,54]
37 40/40 UW6756 Urine GER 2006 This study, [53,54]
38 40/40 UW7790 Feces POL 2007 [53-55]
39 40/40 1638/07 Urine DEN 2007 [13]
40 40/40 3992/09 Urine NLD 2009 [13]
Control 6/2 V583 Blood USA 1981 [36,56]
VA, ventricle aspirate; PF, peritoneal fluid; DEN, Denmark; ESP, Spain; GER, Germany; ITA, Italy; NDL, The Netherlands; NOR, Norway; POL, Poland; SWE, Sweden;
USA, The United States of America.
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Inc, Mukilteo, WA) at 52°C for 15 hours. Slides were subse-
quently scanned using an Axon GenePix ® 4000B scanner.
Immediately after scanning, the slides were stripped for
90 min according to the manufacturer’s protocol. Control
scans were performed each time to monitor possible back-
ground of the subsequent re-hybridization. The slides were
stripped up to 6 times.
Data analysis
E. faecalis V583 [36] was used as a technical replicate
control on each fourplex array. Specifically, given that both
the E. faecalis V583 genome and array probe sequences are
known, number of false positive hybridizations could be
monitored. A signal intensity cut-off could therefore be de-
termined for each array, which reduces these hybridizations
with more than 95%. The entire dataset was then normal-
ized using quantile normalization. The overall correlation
for all technical replicates included in study was 0.95, (see
the correlation matrix for quantile normalized technical
replicates in Additional file 1: Table S1). A hierarchical clus-
ter diagram of hybridization data made in R calculated the
distance by the method “complete”. Principal component
analyses (PCA) and a cluster dendrogram were run on the
resultant quantile normalized matrix (see Additional file 2:
Figure S1A and B, respectively). The presence or absence of
each target in each of the 40 clinical E. faecium ST17 (n =
10) and ST78 (n = 10) and E. faecalis ST6 (n = 10) and
ST40 (n = 10) is presented in Additional file 3: Figure
S2A-E. Each target is represented as a mean value of its
1–5 probes. Number of probes and probe sequences
are listed in Additional file 4: Table S2.
Probe design and final target list
The bioinformatics analysis and probe design of initially
405 targets sequences was done by CustomArray sup-
port (http://customarrays.com/index.htm) (last accessed
December 10th, 2014). A total of 133 targets were excluded
due to sequence similarity (>90%), sequence quality, and
misleading annotation in GenBank. For the remaining 272
target sequences, 1–5 probes were designed. Suggested
probes were blasted against a database built of the following
enterocccal genome sequences: (E. faecium DO (GenBank
acc. no. AAK03000000), E. faecium strains E1039 (NZ_
ACOSO1000000), E1071 (NZ_ABQI00000000), E1162
(NZ_ABQJ00000000), E1636 (NZ_ABRY00000000), E1679
(NZ_ABSC00000000), E980 (NZ_ABQA00000000), and
U0317 (NZ_ABSW01000000), and the E. faecalis strains
OG1RF (CP002621), TX0104 (NZ_ACGL00000000),
and TX1322 (NZ_ACGM00000000). Probes with most
homologues (increased probability of false positive hy-
bridizations) were excluded. The resulting 1250 probes
were Tm-balanced by altering their length between 35
and 40 nucleotides. Number of final probes for each
target and probes sequences are given in Additional file
4: Table S2.
The final target list included plasmid backbone genes
(n = 85) encoding replication initiation proteins, genes
associated with plasmid conjugation maintenance and
plasmid addiction systems; transposable elements (n = 85)
including conjugative transposons (integrases, excisionases
and relaxases), Tn3 family of transposons (transposases and
resolvases), transposases associated to known IS elements,
and other targets associated to transposable elements;
genes encoding resistance (n = 67) towards relevant an-
tibiotics (glycopeptides, aminoglycosides, β-lactamases,
tetracyclines, macrolides/lincosamides/streptogramins
B (MLSB antibiotics), linezolid, chloramphenicol, and
trimethoprim), biocides (disinfectants), and heavy metals;
prophage sequences (n = 29) and CRISPR-cas sequences
(n = 6). Thirty six plasmid replicon variants associated
with enterococci were included in the analyses. Previously
defined 20 reps [21,24] are designated by subscripted
number representing replicon type and/or the name of the
reference plasmid in Additional file 5: Figure S3A.
PCR
The presence of important targets rejected during the
probe design or targets representing newly described
mobile genetic elements were examined by specific
PCRs. They included aac(6’)-aph(2”)-Ia encoding the
bi-functional aminoglycoside-modifying enzyme [57],
the vanA and vanB clusters [38,58,59] as well as genes
encoding the replication initiation proteins of plas-
mids pLG1 [29,60], pCF10 [24] and pIP501 (repR)
[24]. To detect both ω-ε-ζ phylogenetic subgroups
[17], the following primer pair specific for conserved
regions were used: EU2f: 5′-GGCGGAAACGTAAAA
GAAGTTATG-3′ and EU4r: 5′-TTCATTGACCGC
CAATACTCATG-3′.
Antimicrobial susceptibility testing
Antimicrobial susceptibility testing (AST) of the strains
was performed to examine the validity of the microarray
hybridization results for defining antimicrobial resistance
determinants. AST towards ampicillin (2 μg), erythro-
mycin (15 μg), gentamicin (30 μg), linezolid (10 μg), and
tetracycline (30 μg) were done according to EUCAST
(European Committee for Antimicrobial Susceptibility
Testing) disk diffusion method [61]. Vancomycin suscep-
tibility was examined using the brain heart infusion
(BHI) agar screen method [62] using BHI supplemented
with 6 mg/L vancomycin. The EUCAST clinical break-
points [63] or clinical breakpoints defined by Clinical
and Laboratory Standards Institute (CLSI) for antimicro-
bials not defined by the EUCAST were used for inter-
pretation of AST.
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Statistical calculations
The statistical differences in hybridization profile of selected
targets between either the two species (E. faecium/E. faeca-
lis) or between STs within the two species (ST17/ST78 or
ST6/ST40, respectively) were assessed by chi square (χ2)
calculations without corrections and with 1 degree of
freedom using the online calculator http://graphpad.com/
quickcalcs/contingency1/ (last accessed December 10th,
2014). P-value <0.05 was considered significant.
Results and discussion
Clinical relevant strains of European origin belonging to
four predominant STs from the two decades of 1990 and
2000 were chosen for this study; E. faecium ST17 and
ST78 which represent Bayesian Analysis of Population
Structure (BAPS) groups 3–3 and 2–1 and E. faecalis
ST6 and ST40 of CC2 and CC40, respectively. The DNA
microarray was designed to cover mobile genetic ele-
ments (including antimicrobial resistance determinants)
and CRISPR-cas elements associated with enterococci
and known at that time.
Overall hybridization profile and quality
A PCA was applied on the overall dataset and visualized
in a two-dimensional plot (see Additional file 2: Figure
S1A), also a dendrogram was created to visualize the re-
sult of a hierarchical clustering calculation of the mobi-
lome (see Additional file 2: Figure S1B). The overall
hybridization pattern showed E. faecium ST17 and ST78
clustered while the E. faecalis ST6 and ST40 formed two
valid subgroups. As these data covers genes mainly in-
volved in HGT and to a much less extent vertical des-
cent, this does not describe the clonal relatedness of the
strains analyzed. MLST-based data show that E. faecium
ST17 and ST78 belong to two different BAPS groups
(see above) suggesting that both STs are part of different
hospital lineages and followed different evolutionary tra-
jectories [64]. Although analyzing different strains than
ours, the phylogenetic distance between E. faecium ST17
and ST78 is partly addressed through WGS by Lebreton
et al. showing these strains grouped in one clade (clade
A1) [6]. Within this clade, however, ST17 and ST78
cluster in different lineages, suggesting a certain degree
of common evolutionary background yet diversification
into separate genetic lineages. The highly-common mobi-
lome found in our E. faecium ST17 and ST78 strains is
most likely the result of sharing a common ecological
niche (hospital) in which a common set of accessory genes
is necessary to survive and thrive rather than evolutionary
relatedness. Complete relatedness can be inferred by next
generation sequencing (NGS), however, this is not the
scope of our study. The DNA microarray technique was
preferred over NGS as we searched only for absence or
presence and not localization of specific targets. Also,
reliable de novo whole genome assemblies from Illumina
data addressing the mobile genome content is limited
[65-67]. The dots representing every application of the
control strain, E. faecalis V583 (ST6) form a tight cluster
ensuring the comparable quality of the slides. The PCA
shows that the selected targets in this array are both
species- and ST-specific. Thus, the overall results of the
PCA indicate that the dataset is technically accurate and
biologically relevant. The accuracy of each repeat of the
hybridization was also monitored by correlating the over-
all hybridizations of the technical replicate E. faecium
V583 included in each fourplex array (Additional file 1:
Table S1 and Materials & Methods). A correlation of
0.95 was obtained. As an additional quality control of
the array, the presence and absence of antimicrobial re-
sistance markers were compared with antimicrobial suscep-
tibility testing and by selected consensus PCR analyses.
This revealed that the results from the verifications were in
agreement with the microarray hybridization results close
to the expected 95% accuracy (data not shown).
Species- and ST-specific patterns of mobile genetic
elements
The detailed MGE gene profile of the 40 sample strains
is given in Additional file 3: Figure S2A-E. The data are
summarized for each of the four STs in Additional file 5:
Figure S3A-E, significant differences (p < 0.05) between
species and STs are indicated. The major species and
ST-specific patterns are categorized and discussed below
in relation to difference in content of plasmids, trans-
posable elements, antimicrobial resistance determinants,
prophages and CRISPR-cas modules.
Frequently detected plasmid associated gene targets
Plasmid-encoded genes involved in conjugation and
mobilization as well as replication and maintenance
were assessed by microarray hybridization analyses or,
for a few targets, by PCR (Additional file 3: Figures
S2A and Additional 5: Figure S3A). In order to sort out
biological relevant patterns within the complexity
caused by the modular structure of plasmids and the
propensity of inter-plasmid recombination events, we
defined the plasmid content in the four STs by presence
of rep genes encoding replication initiator proteins and
TA-encoding genes.
The average number of detected reps per strain for
E. faecium and E. faecalis (n = 6.75 and n = 5.45, respect-
ively) were higher than previously reported for invasive
E. faecium (3.2; [29]) and for clinical isolates of E. faeca-
lis (2.54; [26]). This might reflect higher plasmid content
in the selected STs, but may also be due to the higher
number of rep targets included in the array. We suppose
the factual number of plasmids to be lower than the
identified rep genes since multi replicon plasmids and
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plasmid remnants in the core chromosome are known
for many bacteria including enterococci [21,48].
As shown in Additional file 5: Figure S3A, rep targets
belonging to the RCR, Rep_3, RepA_N, and Inc18 plasmid
families (as defined by [68]) were well represented in both
E. faecium (n = 34; n = 28; n = 36; and n = 21, respectively)
and E. faecalis (n = 27; n = 6; n = 36; and n = 28, respect-
ively). With the exception of the Rep_3 family (see below),
there were no significant differences between the species or
between the STs for the included strains. However, the
composition of replicon types (as defined by [24]) within
each plasmid family differed highly between E. faecium and
E. faecalis and for some rep types between the STs as indi-
cated. Our findings are in accordance with previous reports,
although the composition and prevalence of the reps appear
to vary between strain collections of different origins
[17,21,26,29].
The rep14 belonging to the RCR family was the most
abundant replicon type in the strain collection with a
significant (p < 0,0001) higher prevalence in E. faecium
(n = 32) than in E. faecalis (n = 8). The rep14 replicons,
which include the small mobilizable plasmids pEFNP1,
pKQ10 and pRI1, have been considered specific for E.
faecium [24,68-70]. Sequences originating from pEFNP1
and pKQ10 were prominent in a hospital clade specific
E. faecium plasmid library [14]. Interestingly, the rep of
pEFNP1 (target 19) was also found in half of the E. fae-
calis ST40 strains included in our study. Plasmids of
rep7/pUSA02 type have been obtained from a broad range
of hosts (Enterococcus, Staphylococcus, Streptococcus and
Bacillus) and were represented in the array (target 431)
by a repD of an E. casseliflavus plasmid [71]. Strikingly,
the rep7 replicons were found in 12/20 of the E. faecalis
strains, but only in two E. faecium strains (p < 0.0001).
Taken together, the replicons of the RCR family appear
to be abundant with a species-specific profile. Neverthe-
less, our observations support the notion that the exam-
ined STs of E. faecium and E. faecalis could share a pool
of cryptic small plasmids through HGT. Their potential
role of in the evolution of clinically important lineages
of enterococci remains to be examined.
Rep_3 family includes several plasmids previously de-
scribed in enterococci [72-75]. In our strain collection, a
significant higher prevalence of Rep_3 family replicons
were detected in E. faecium (n = 28) compared to E.
faecalis (n = 6; p < 0.0001). In E. faecium represented
by rep18 (n = 11), rep11 (n = 10) and reppCIZ2 (n = 7),
the two latter have a higher prevalence in ST78 com-
pared to ST17 (p = 0.0377 and P = 0.0191, respect-
ively). In E. faecalis, Rep_3 plasmids were represented
by rep5/pN315 (n = 2), rep6/pS86 (n = 2) and rep11/pB82 (n = 2).
This highly species-specific distribution of replicons indi-
cate a narrow host range profile of the Rep_3 family. Their
high abundance in the E. faecium strains compared to E.
faecalis, might reflect a specific role of this plasmid family
in the development of these important clinical lineages of
E. faecium.
RepA_N is the most prevalent plasmid family, but with
significant differences in rep types between the two spe-
cies for the included strains. This is in accordance with
the description of RepA_N replicons as narrow host
range plasmids [76]. The rep9 variants of pheromone re-
sponsive plasmids [36,77-79] considered specific for E.
faecalis were frequently detected in these strains but
were absent in the E. faecium strains (p < 0.0001). Posi-
tive PCR results for prgW of pCF10 were observed in all
E. faecalis ST6 strains. The par genes, encoding toxin
RNAI and antitoxin RNAII originally found on the
pheromone responsive plasmid pAD1 in E. faecalis [80],
were found in 10/20 of the E. faecalis strains, were also
absent in the E. faecium strains (p < 0.0001). On the
other hand, the rep17/pRUM and rep20/pLG1 replicons were
present in 18/20 and 14/20 of the E. faecium strains, re-
spectively, but absent in E. faecalis (p < 0.0001). rep17/pRUM
was the single most dominating replicon type among the
selected E. faecium strains. This is consistent with previous
reports, which also link the axe-txe TA-loci to this replicon
type [17,21,41,48,81]. Both the axe and the txe targets (457
and 458) hybridized to 15/20 E. faecium strains, while none
of the E. faecalis strains were positive (p < 0.0001). More-
over, co-hybridization with the axe-target was observed for
17/18 of the rep17/pRUM positive and 12/14 rep20/pLG1 posi-
tive (data not shown) E. faecium strains. Also for rep20/pLG1,
our findings are in agreement with previous investigations,
where this rep was detected in 90% of E. faecium blood cul-
ture isolates [26] and linked to axe-txe on large conjugative
plasmids encoding high-level gentamicin resistance [26] or
glycopeptide resistance [19,50,60]. Our confirmatory find-
ings support the importance of rep20/pLG1 megaplasmids in
the evolution of hospital-associated lineages of E. faecium.
Moreover, the contribution of axe-txe for the stable main-
tenance of clinical important RepA_N family plasmids in E.
faecium is underlined.
The broad host range Inc18 family of conjugative plas-
mids is known to carry multiple antimicrobial resistance
genes, including specific MLSB-resistance determinants
hosted by streptococci, lactococci, staphylococci, and en-
terococci [82]. The pRE25 replicon type (rep2) had the
same prevalence in E. faecium and E. faecalis (14/20), while
rep1, which includes reps from pAMβ1 and pIP501, was de-
tected in 6/20 and 7/20 of the E. faecium and E. faecalis
strains, respectively. No significant interspecies-differences
in distribution of rep types between the included species or
STs was detected, except for reppHTβ (n = 5), which had a
higher presence in ST6 (n = 4; p = 0.0233), which under-
lines the broad host range of the Inc18 plasmid family and
their propensity to support genetic exchange between the
two species. However, Inc18 plasmids may have been
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established in enterococci at an early stage and essentially
propagated by vertical descent.
The ω-ε-ζ TA-sequences included in the array origi-
nated from the Inc18 pVEF plasmids [83,84]. A discrep-
ancy in presence between the three targeted TA-genes,
which can be partly explained by allelic variation in the
operon [17] or presence of the targets in other genetic
contexts, was observed. However, to function as a plas-
mid stabilizing system, the presence of all three gene
products is essential [85]. An additional PCR analysis
using primers directed towards regions conserved for
the two ω-ε-ζ phylogenetic subgroups [17] detected the
TA-locus in a total of 14/20 of E. faecium and 17/20 of
E. faecalis, where all ST40 strains were positive. In
agreement with previous findings [17], co-hybridization
to rep2/pRE25 was observed for E. faecium (11/14) and
for E. faecalis ST6 (6/7), confirming the linkage of ω-ε-ζ
to Inc18 plasmids in gram-positive pathogens and their
contribution in stable persistence of clinically important
plasmid encoded resistance traits (reviewed by [31]).
However, ω-ε-ζ was also detected in the absence of
rep2/pRE25 in both E. faecium (n = 3) and E. faecalis
(n = 6) indicating linkage to other replicon types as
well. Indeed, co-localization with rep9 belonging to the
RepA_N family of pheromone responsive plasmids was
reported for E. faecalis [26].
The mazEF originally observed on the Escherichia
coli chromosome is one of the best-characterized TA-
systems and have been identified in a large number of
bacterial species [86,87]. For Enterococcus, the E. coli
mazEF sequence has been reported to be ubiquitously
present on vanA-plasmids in VRE strains including E.
faecium and E. faecalis [28]. However, the E. coli
mazEF could not be detected in an epidemiologically
diverse collection of E. faecium strains [17] and BLAST
search (http://www.ncbi.nlm.nih.gov/pubmed; last accessed
December 10th 2014) among draft genomes and plasmids
did not show its presence in Enterococcus. In the current
study the sequences from E. faecalis EnGen0297 strain
HH22 (ACIX01000197.1) annotated as putative MazE
and MazF were included (targets 464 and 465). All E.
faecalis strains (n = 20) were positive for both targets,
while the mazEF targets were not found in the E. fae-
cium strains (p < 0.0001). BLAST search (last accessed
December 10h 2014) for the mazEF target DNA re-
vealed a high prevalence in E. faecalis genomes where
it appeared to be highly conserved, while no DNA
homology was found in the E. faecium genomes, which
is in accordance with our findings. However, conserved
ORFs encoding putative MazF homologues were preva-
lent among the E. faecium draft genomes, indicating
evolutional segregation of the two species. The func-
tionality and linkage of these mazEF genes to the mobi-
lome of Enterococcus need to be further investigated.
Widely distributed transposable elements
In addition to plasmids, three groups of transposons
have been shown to facilitate flux of antimicrobial resist-
ance determinants in enterococci [2]. Composite trans-
posons transpose accessory DNA due to homologous
flanking IS elements. Moreover, the Tn3 family of trans-
posons encode replicative transposition, and conjugative
transposons support their own transfer between bacteria
[2]. Our mobilome array included relevant members
from all these three groups previously shown to be asso-
ciated with enterococci. The IS elements belonged to
families described by Clewell [68] and IS Finder (http://
www-is.biotoul.fr/) (last accessed December 10th, 2014).
Different transposable elements in E. faecalis and E.
faecium
A total of 12 IS families and 9 transposon groups were
represented in our array. Additional file 3: Figure S2B
shows the gene profile of all targets included in the
microarray, which represents in many cases sequences
of several transposases of the same IS family. Represen-
tative targets and their distribution are summarized in
Additional file 5: Figure S3B, illustrating the predomin-
ance of transposable elements in E. faecium investigated
clones (p < 0.0001). However, most of the selected tar-
gets represented transposable elements from this species
and thus the relative overrepresentation of these targets
among E. faecium is not unexpected. In particular, trans-
posases of the IS families IS256 (p = 0.0026), IS3 (p <
0.0001), ISL3 (p < 0.0001), IS200/IS605 (p = 0.0058),
IS110 (p = 0.039), IS982 (p < 0.0001), and IS4 (p =
0.0079) were significantly more abundant in E. faecium
than E. faecalis. None of the included IS families were
found at higher frequencies in E. faecalis strains than in
the E. faecium strains although 10 of the 11 IS families
represented in E. faecium were also found in E. faecalis.
The presence of IS families in both E. faecalis and E. fae-
cium specific strains imply that these elements are
spread by HGT. However, particular IS elements are dis-
tributed in only one species suggesting that these IS ele-
ments have evolved over time within this species to
become different from the other IS family members.
Many variants of the Tn916 family conjugative transpo-
sons have been reported (for review see [22]) and
BLAST searches (last accessed December 10th 2014)
show that both the original Tn916 and most of the vari-
ant transposons are reported in E. faecalis. For both rea-
sons it is plausible that the conjugative transposon
Tn916/Tn1545 was observed more frequently in the
investigated strains of E. faecalis (p < 0.0001) than E. fae-
cium (Additional file 5: Figure S3B). Furthermore, Tn916
have also been associated with pheromone responsive
plasmids in E. faecalis [88,89], which accelerates their
transfer among E. faecalis.
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Abundant IS families and their possible association with
resistance genes and transposons
The IS256 family members (3 IS256 variants as well as
IS1542, IS16, ISEf1 and IS1310) are important compo-
nents of many composite transposons conferring anti-
microbial resistance such as Tn5281 and Tn4001 encoding
HLGR [90], Tn1547 (encoding vancomycin resistance
[91,92]) and Tn5384 (encoding erythromycin and gentami-
cin resistance [93]. Integrated IS256-like elements have also
been observed in the Tn3 family (Tn1546) [23,49,94]) and
conjugative transposons (Tn5382) [39]. With the exception
of IS1542 and IS1310, the IS256 family members in this
study are found in the majority of the E. faecium strains
(13/20 to 20/20) and in 7/20 to 20/20 E. faecalis strains.
The presence of ISEf1, IS16 and IS1542 (target 134, 98 and
102) [49], which is often observed among Tn1546 variants
does not correlate with the presence of this transposons
(see Additional file 3: Figure S2B and Additional file 5:
Figure S3B for details).
A study of E. faecium strains from different niches
using comparative genomic hybridization (CGH) indi-
cated an IS-driven diversification of hospital-adapted E.
faecium strains [14]. Notably, IS16 was suggested as the
most hospital clade-specific marker in E. faecium (with
98% sensitivity and 100% specificity). This observation
was further supported by detecting IS16 in 155 of 160
invasive E. faecium strains, in contrast to only three positive
for this elements among 100 E. faecium strains of human
commensal, animal or food-associated origin [45]. All our
clinical E. faecium strains were positive for IS16, while only
three E. faecalis strains contained this sequence.
The IS3 family was represented in this array by
ISEnfa3, IS1485, IS3-like, and IS981 transposases. IS981,
which is mostly reported in lactococci, was found in 17/
20 E. faecium strains and 12/20 E. faecalis strains.
IS1485, which is widely spread in many enterococcal spe-
cies [95], were found in all tested strains. The putative
transposase of ISEnfa3 was found in all E. faecium, while it
was absent in E. faecalis (Additional file 3: Figure S2B and
Additional file 5: Figure S3B). ISEnfa3 was described as an
epidemiological marker for Tn5382 in South Korean E. fae-
cium [96]. However, only three ST17 E. faecium strains
were positive for Tn5382, thus ISEnfa3-like elements do
not seem to be associated with Tn5382 in our strains.
The ISL3 family represented by transposases from
ISL3, ISL3-like, IS1251, ISEfa11, IS1476 and IS1167
dominated in the E. faecium strains with the exception
of two ISL3-like transposons (see Additional file 3:
Figure S2B and Additional file 5: Figure S3B for de-
tails). The presence of IS1251, ISEfa11 and IS1476
transposase sequences which were reported integrated
in Tn1546-like elements [97-101] did not correlate
with presence of Tn1546 (see Additional file 3: Figure
S2B and Additional file 5: Figure S3B for details).
The abundance of the IS200/IS605 family in E. fae-
cium was due to ISEfa4 and an E. faecium DO IS605
transposase, while an IS200 transposase from E. faecalis
V583 was only found in E. faecalis (Additional file 3:
Figure S2B and Additional file 5: Figure S3B). A putative
ISEnfa200 transposase described previously as being in-
tegrated in the vanB cluster of Tn5382 [93] was not
found in any of these strains. ISEfa4 was found in a vanS
gene of a vanD genotype VRE strain [102] as well as
within a Tn1546 element [103-105]. However, in our
strains ISEfa4 presence did not correlate with the pres-
ence of Tn1546 (Additional file 5: Figure S3B).
The IS110 family represented by three transposases
was also significantly more abundant in E. faecalis ST6
than ST40 strains (p = 0.0027). This was due to the
presence of IS110 target 165 transposase in ST6 while
IS110 target 167 transposase dominated in E. faecium
(Additional file 3: Figure S2B and Additional file 5:
Figure S3B). The third transposase representing the
putative ISEnfa110 described previously integrated in
Tn5382 [92] was not found in any of these strains.
ISEfm1 representing the IS982 family has only been
reported in a vanD operon of a vancomycin resistant E.
faecium strain [106]. This IS element was present in all the
E. faecium isolates and was also significantly more frequent
in E. faecalis ST6 than ST40 strains (p = 0.025) (Additional
file 3: Figure S2B and Additional file 5: Figure S3B).
The IS4 transposase can be found in many enterococcal
genomes, mostly in E. faecium, This is in accordance
with our results, where it was found in 6/20 E. faecium
strains only.
The IS1182 family represented by IS1182 transposase
is more numerous in E. faecalis ST6 than ST40 strains
(p = 0.0034) and is also present in 7/20 E. faecium strains
(Additional file 3: Figure S2B and Additional file 5:
Figure S3B). This IS element delimits the streptococcal
composite transposon Tn5405 carrying resistance to
aminoglycoside-streptothricin (aadE-sat4-aphA-3) [107]. In
multiple-resistant E. faecium Tn5405-variants were also
found genetically linked to the MLSB determinant ermB
and in one case also to the glycopeptide resistance cluster
vanA [108]. In concordance with this, IS1182 was in this
study observed to be present only in strains containing
sat4, aphA-3/aph(3)-IIIa and ermB/erm2 (targets 247, 381
and 298, respectively). However, these resistance genes were
observed also in strains lacking IS1182 (Additional file 3:
Figure S2B).
Due to IS1678, the IS1380 family also represented by
an ISEcp1-like transposase, was statistically more preva-
lent in ST78 than ST17 E. faecium (p < 0.0001) (Additional
file 3: Figure S2B and Additional file 5: Figure S3B).
IS1678 has previously only been reported twice integrated
in Tn1546 [109] and close to Tn1546 on a rep17/pRUM rep-
licon [110] in E. faecium. These IS1678 elements were,
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except for two strains, not associated with Tn1546 con-
taining strains and detected in only 7/18 E. faecium strains
containing the rep17/pRUM replicon in our study.
Predominant transposable elements encoding clinically
relevant antimicrobial resistance
To visualize the impact of resistance markers on the
overall dataset, a second PCA excluding data from the
targets encoding resistance markers was built (data not
shown). This did not alter the overall plot substantially
suggesting the resistance markers to be generally genet-
ically linked to the other included MGEs.
The Tn916/Tn1545 family of conjugative transposon
(CTn) is widespread, but primarily observed in the
Firmicutes such as enterococci. This CTn-family seems
to have a particular ability to acquire accessory genes
including resistance determinants, to cause genome rear-
rangements and to mobilize other replicons. The originally
described Tn916 carries the tetracycline resistance gene
tetM. Tn1545 is homologous to Tn916, but contains add-
itionally ermB (encoding resistance to MLSB antibiotics)
and aphA-3 (encoding resistance to kanamycin) cassettes
(reviewed in [111,112]). In our array the Tn916/Tn1545
family was represented by an integrase (target 199), an exci-
sionase (target 213) and a conjugative transfer protein gene
(target 75) as well as the tetracyclin resistance determinant
tetM (target 243). The integrase, excisionase and conjuga-
tive transfer protein genes were significantly more abun-
dant in E. faecalis than E. faecium (p < 0.0001) as well as in
ST17 than ST78 (p = 0.02) of E. faecium (see Additional file
3: Figure S2B and Additional file 5: Figure S3B for details).
All E. faecalis strains hybridized to the Tn916 targets while
the Tn916 specific integrase and excisionase were detected
in only 2/10 ST17 and were absent in ST78 E. faecium. The
esp-containing ICEEfm1 has a conjugation module similar
to Tn916 [113]. However, the conjugative transfer protein
from this conjugation module shows only about 80% iden-
tity at protein level to the Tn916 prototype protein (ORF16
target 75) and thus the DNA identity level was far too low
to detect ICEEfm1 through the Tn916 conjugation protein
in our array.
The Tn3 transposon family transposon Tn1546 is gen-
etically linked to the vanA resistance cluster encoding
high-level glycopeptide resistance [114]. In our array tar-
get 146 represents the transposase [83,115], target 216
the associated resolvase [83,114] and target 237 the
prototypical D-ala:D-lac ligase (vanA) of Tn1546 [115],
which were present in the same strains except for vanA
which was found in an additional ST17 strain (Additional
file 3: Figure S2B and Additional file 5: Figure S3B). PCR
(vanA) and phenotypical analysis (vancomycin) confirmed
the hybridization patterns (Additional file 5: Figure S3C
and data not shown).
The conjugative transposon Tn5382/Tn1549 is closely
linked to the vanB2 gene cluster [92,116,117]. This
transposon was represented in our array by probes tar-
geting the genes of the excisionase of Tn1549 (target
454), the integrase (target 452), the relaxase (target 39),
the TrsE-like protein (target 82), and the D-alanine:D-
lactate ligase (vanB; target 238) (Additional file 3: Figure
S2B and C, Additional file 5: Figure S3B and C). A mod-
erate number of the E. faecium and E. faecalis strains
hybridized to these targets. PCR analyses and antimicro-
bial susceptibility testing confirmed that vanB was
present only in isolates containing all Tn5382/Tn1549-
related targets.
Broad content of genes encoding antimicrobial resistance
The enterococcal STs in this study were selected due to
their relative dominance in clinically relevant strains. Al-
though the presence of resistance traits was not a selection
criterion, the collection is biased towards antimicrobial re-
sistance and an overrepresentation of these markers was
expected. The phenotypic expression of resistance, exam-
ined by standardized AST, was used to validate the
hybridization results for defined antimicrobial resistance
determinants. Moreover, the presence of vanA, vanB and
aac(6’)-aph(2”)-Ia (determining high-level gentamicin re-
sistance) was also examined by PCR.
The hybridization results of screening for the antimicro-
bial resistance determinants are shown in Additional file
3: Figure S2C and summarized in Additional file 5: Figure
S3C. The results are categorized according to genes en-
coding resistance towards glycopeptides, aminoglycosides,
β-lactams, tetracyclines, MLSB, oxazolidinone, chloram-
phenicol, trimethoprim, biocides and heavy metals. As
shown by PCA and cluster dendrogram (see Additional
file 2: Figure S1A and B) a separation in gene content be-
tween the two species and the two STs of E. faecalis can
be seen. Defined resistance markers were selected for
phenotypic verifications, and we observed an overall high
correlation as outlined below.
Vancomycin resistance determinants were represented
by six targets (237 for vanA; 238 for vanB; 280 for vanE;
281 for vanG; 284 for vanG2; 313 for vanL). A total of
3/10 ST17 and ST78 E. faecium and ST6 E. faecalis
strains were positive for the vanA target (Additional file
5: Figure S3C). The vanB target scored positive in 2/10
ST17 and ST78 E. faecium strains. The vanG and vanL
targets scored positive only in one and two E. faecalis
ST40 strains, respectively (Additional file 5: Figure S3C).
Phenotypic testing was in agreement with the hybridization
results except for the vanG and vanL target positive ST40
strains (data not shown). A total of 16/40 strains expressed
vancomycin resistance of which ten and six strains were
confirmed as positive for vanA or vanB by PCR, respect-
ively. As compared to vanA-, vanB- and vanG-specific
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PCRs, the microarray hybridization results yielded two false
negative results (one vanA and one vanB E. faecium) and
two potential false positive results (one vanA E. faecium
and one vanG E. faecalis). Phenotypically silent vanA-deter-
minants have previously been reported [118-120].
The presence of aminoglycoside resistance determinants
showed species and ST-specific patterns. The E. faecium
species-specific target aac(6”)-Ii (target 254) encoding an
aminoglycoside 6′-N-acetyltransferase that mediates resist-
ance towards many aminoglycosides except gentamicin was
present in all E. faecium strains (Additional file 5: Figure
S3C). Target 247, 383 and 381 representing sat4, aadE and
aph(3)-IIIa, respectively, were present in at least 10/20
strains of both E. faecium and E. faecalis (Additional file 5:
Figure S3C). Other targets representing aminoglycoside
resistance determinants were only sporadically present.
The gene cluster aadE-sat4-aphA-3 has been linked to
composite transposon Tn5405 delimited by IS1182
[107]. All three resistance genes were found in 21/40 of
the isolates (Additional file 5: Figure S3C) although
aadE was additionally present in four, sat4 in one and
aphA-3 in three isolates. IS1182 was present in 13/21
of the isolates that contained all three resistance
determinants.
Due to sequence quality (lengths of nucleotides with
adequate Tm) and target homology problems, the target
encoding the bifunctional enzyme AAC(6’)-Ie-APH(2”)-
Ia conferring HLGR was not represented on the array.
The presence of the aac(6’)-Ie-aph(2”)-Ia gene was
therefore analyzed by PCR and yielded 11/20 and 9/20
of E. faecium and E. faecalis positive for this gene, re-
spectively. Notably, 7/10 E. faecalis ST6 while only two
E. faecalis ST40 were positive for aac(6’)-Ie-aph(2”)-Ia.
A strong correlation between the presence of aac(6’)-Ie-
aph(2”)-Ia gene and HLGR was observed (data not
shown). This observation is consistent with a recent
study of European E. faecalis strains that showed a high
prevalence of HLGR in CC2 (96%) in contrast to CC40
(5%) strains [13].
Determinants of tetracycline resistance were represented
by five targets (243 for tetM; 242 for tetL; 262 for tetK; 385
for tetO; 386 for tetS). Using the CLSI clinical breakpoints,
a total of 29/40 strains expressed tetracycline resistance
(data not shown). Hybridization analyses revealed that all
tetracycline resistant strains harbored one; two or three
tet-resistance determinants (see Additional file 3: Figure
S2C and Additional file 5: Figure S3C for details). Only
2/11 tetracycline susceptible strains carried tet-resist-
ance determinants (tetM and tetL), of which both were
E. faecium ST78 strains. Interestingly, all E. faecalis
strains expressed tetracycline resistance and were shown to
carry tetM (n = 20), tetL (n = 4) or tetK (n = 4). Thus, there
is a strong correlation between the presence of Tn916/
Tn1545 targets and tetM resistance determinants in E.
faecalis. This observation is in contrast with the findings
obtained for E. faecium where eight tetM positive strains
were negative for Tn916 xis and int targets. This is even
more pronounced than the data from Polish VRE E. fae-
cium isolates where 59 of 72 isolates containing tetM also
were positive for the Tn916 integrase gene [42]. These
observations could be explained by the location of tetM in
other conjugative transposons such as Tn5801 or Tn6000,
frequently found in E. faecium [68]; (Leon-Sampedro, personal
communication).
Erythromycin resistance determinants were repre-
sented by eight targets (260 for ermA; 298 for ermB;
398 for ermF; 399 for ermG; 401 for ermQ; 396 for
ermT; 402 for ermTR; 309 for mef ). A total of 31/40
and 8/40 strains showed resistance or intermediate
susceptibility to erythromycin using the CLSI clinical
breakpoints for interpretation (data not shown).
Hybridization analyses revealed that all erythromycin
resistant strains harbored one of these erythromycin
resistance determinants (ermB n = 29; ermT n = 1; mef
n = 1). One susceptible strain was positive for ermB.
Determinants ermA, ermF, ermG, and ermQ were not
detected. Four out of 8 intermediate strains did not
contain any erythromycin resistance determinants,
while the other four were positive for ermB (n = 1),
mef (n = 2) or mef + ermT (n = 1). One strain was sus-
ceptible and also negative for all erythromycin resist-
ance determinants. Acquired resistance towards MLSB
in enterococci is most often due to the presence of the
ermB gene [121-126]. ermB was identified in 17/20 E.
faecium strains as well as 10/10 and 3/10 E. faecalis
ST6 and ST40 strains, respectively (Additional file 5:
Figure S3C). Although ermB was originally described
as part of Tn917 in E. faecalis [127] we do not find a
correlation between presence of ermB and Tn917 tar-
gets that were found only in 1 (resolvase target 229)
and 2 (transposase target 145) of the 10 ST6 E. faecalis
strains. However, ermB presence have been reported
on different plasmids [114,128-131] suggesting that
ermB is transferred by plasmids among enterococci.
Several chloramphenicol acetyltransferases of different
origins were represented on the array (targets 387–393;
Additional file 4: Table S2). Target 390 scored positive in
5/20 E. faecalis and 3/20 E. faecium strains, while target
387 scored positive in 9/20 E. faecalis strains (Additional
file 5: Figure S3C). Antimicrobial susceptibility testing
towards chloramphenicol was not performed. Finally, an
oxazolidinone target (target 394) representing a gene en-
coding rRNA methylase Cfr from a Staphylococcus war-
neri plasmid was present on the array and one E.
faecalis strain ST40 scored positive for this target. How-
ever, the strain was susceptible to linezolid, also PCR
analysis did not detect the cfr gene (data not shown) in-
dicating unspecific hybridization.
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When summarizing the relative presence of the different
antimicrobial resistance determinants (n = 67) E. faecalis
ST40 strains had the highest positive score (average of
10.5% positive targets per strain) as compared to E. fae-
cium ST17, E. faecium ST78 and E. faecalis ST6 with an
average of 6.6%, 6.9%, and 7.4%, respectively (Additional
file 3: Figure S2C). The tetM, tetS and msrC genes, respon-
sible for tetracycline and erythromycin resistance, respect-
ively, contributed largely to this difference (Additional
file 5: Figure S3C).
High prevalence of genetic determinants for cadmium and
QAC resistance in E. faecalis ST40
While the selected targets representing resistance traits
towards copper (406 for tcrB), mercury (407 for merA
and 408 for merB), cadmium (409 for cadA), and quater-
nary ammonium compounds (QAC) (410 for qacA, 412
for smr/qacD, 413 for qacG, 414 for qacH and 415 for
qacJ) seem uncommon in the E. faecium strain collection,
a number of E. faecalis and in particular ST40 strains
hybridized to them (see Additional file 3: Figure S2C and
Additional file 5: Figure S3C for details). Hybridization
occurred mainly in the strains most recently recovered
(2006–2009, Additional file 3: Figure S2C). The cadmium
and QAC resistance determinants were found in the same
6/10 E. faecalis ST40 strains as well as in 1/10 ST6 strain
but the possible genetic linkage of these resistance deter-
minants will have to be investigated by other methods.
Biocide (e.g., alcohol, aldehyde, biguanides (chlorhexi-
dine), quartenary ammonium compounds, zinc, phenolic
compounds) resistance has been rarely detected among
enterococcal strains, despite its frequent detection in
clinical isolates of other Firmicutes, e.g. the emergence
of QAC resistance in Methicillin Resistant Staphylococ-
cus aureus due to acquisition of plasmid-borne qac
genes [132,133]. Further, evidence suggests that biocide
and antibiotic resistance determinants are linked within
the same genetic unit raising the question if the use of
biocides can contribute to the selection of antimicrobial
resistance [134-139]. However, the previous observed
co-localization of the copper resistance determinant with
ermB [136,137] or vanA [136] in enterococci from ani-
mals was not observed in this strain collection repre-
senting four highly prevalent, clinical relevant ST types.
Delimited presence of prophage determinants
Although transduction of virulence and resistance genes
were recently demonstrated in enterococci [139,140], the
extent and importance of HGT due to bacteriophages in
enterococci is not fully understood. Prophage sequences
are commonly found in CC2 strains [19] including the
fully sequenced E. faecalis V583 which harbors seven
prophage-like elements [36,141], six of which are proven
biologically active [142]. Based on the current knowledge
on these sequences at the time the array was printed,
five of them (pp1, pp3, pp4, pp6, and pp7) were repre-
sented in our assay, Additional file 3: Figure S2D and
Additional file 5: Figure S3D. With the exception of one
strain from each species, the E. faecalis V583 prophage
sequences were present in all E. faecalis test strains, and
in none of the E. faecium strains. Prophage7 (pp7) is
able to excise from the chromosome by the aid of pp1 in
a manner that resemble chromosomal islands, and have
therefore been renamed E. faecalis chromosomal island
of V583 (EfcIV583) [132]. This target was only found in
two E. faecalis ST6 strains. Eight different E. faecium
prophage sequences (24 target sequences of various ori-
gins both non-hospital and clinical strains) were repre-
sented on the array [15]. With one exception (prophage
sequences from E. faecium E980, targets 315–317), these
sequences showed species specificity toward E. faecium.
Prophage sequences from the clinical E. faecium ST78
strain U0317 (targets 336–341) dominated the E. fae-
cium strain collection and was especially well distributed
in the ST78 strains.
Recent studies have identified additional phage se-
quences to those included in this array (reviewed in [143])
and one should account a possible different outcome if
these were included. However, prophage sequences are
commonly found in our collection of E. faecium and E.
faecalis strains and are in general species-specific, suggest-
ing HGT events as well as vertical transmission of these
prophage sequences.
Presence of CRISPR-Cas system only in E. faecalis ST40
strains
The Clustered Regularly Interspaced Short Palindromic
Repeat (CRISPR)/CRISPR associated (Cas) system provides
immunity against bacteriophage infections and mobile gen-
etic elements in prokaryotes by genetic memory and (RNA
guided) DNA interference (reviewed in [144,145]). The
CRISPR-Cas system was represented in our array by four E.
faecalis OG1RF CRISPR associated proteins (encoded by
cas- and csn genes; targets 474–477) and two conserved
CRISPR repeat sequences; one from E. faecium (target 478)
and E. faecalis OG1RF (targets 479). None of the 20 E. fae-
cium strains was positive for any of the CRISPR-cas targets
(Additional file 3: Figures S2E and Additional file 5: Figure
S3E). This is in agreement with previous reports on hospital
adapted E. faecium lineages with a broad content of anti-
biotic resistance traits [146] and prophage sequences [15].
This inverse correlation was also expected for the E. faecalis
strains [146,147]; however 90% of the ST40 strains con-
tained both CRISPR and cas sequences, and thus likely a
functional system. All these strains also contained multiple
acquired antibiotic resistance genes challenging the hypoth-
esis of Palmer and Gilmore [146] that multidrug resistant
enterococci generally lack CRISPR-cas genes. A similar
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observation was found in 15 multidrug resistant whole
genome sequenced E. faecalis ST40 isolates showing
supposedly complete CRISPR-Cas systems [148]. It is, how-
ever, difficult to elucidate any possible targets for this
CRISPR-Cas system without sequencing the CRISPR spacer
region to search for specific target sequences.
Conclusions
Our microarray-based study revealed an overall high
prevalence and a species-specific distribution of mobile
genetic elements in the selected clinically relevant E. fae-
cium and E. faecalis. For the E. faecalis strains, the pres-
ence or absence of these targets also separated the two
STs. The separation of E. faecalis ST6 and ST40 was es-
pecially evident for the biocide genes, E. faecalis pro-
phage sequences and cas genes.
Although the presence of broad host range conjugative
Inc18 family replicons substantiates the possibility of
inter-species horizontal gene transfer, both species were
dominated by narrow host range replicons. The high
species-specific prevalence of the RCR family of small
cryptic plasmids, the Rep_3 family and the RepA_N family
including pLG1 megaplasmids and pheromone responsive
plasmids imply an evolutionary significant role in the devel-
opment of the hospital associated STs hosting them.
An association between the ω-ε-ζ plasmid addiction
system and Inc18 plasmids was verified for E. faecium,
but the TA locus was also detected in the absence of
this plasmid family in both species. The contribution of
TA-systems for stable maintenance of important viru-
lence and resistance carrying plasmids in Enterococcus
is also underlined by the high prevalence of the axe-txe
locus and its association to the RepA_N plasmids in
the E. faecium strains.
Specific IS elements are distributed in only one of the
species implying that these have evolved vertically. How-
ever, the presence of most IS families in both specific
strains E. faecalis and E. faecium suggest that these ele-
ments are also spread by HGT. Within E. faecium,
Tn916/Tn1545 and IS1380 were specific for ST17 and
ST78, respectively. All 20 E. faecalis strains contained
sequences of Tn916/Tn1545, while IS families of IS110,
IS982 and IS1182 showed a preference towards ST6.
The relative lack of Tn916 family conjugative transpo-
sons in E. faecium compared to E. faecalis in our strains
fits with most reports of this transposon family in E. fae-
calis. There was also a strong correlation between the
presence of Tn916 targets and tetM in E. faecalis that
was not found in the E. faecium strains. The presence of
Tn917 resolvase and transposase in only one and two of
the 30 strains that harbored ermB correlates well with
few descriptions of Tn917 containing enterococci in the
literature although ermB was originally described as part
of this transposon in E. faecalis.
The overall findings confirm and unfold our previous
knowledge on the extensive reservoir of mobile genetic
elements and underline their importance in evolutionary
development of clinical relevant lineages of enterococci.
Moreover, the detected MGE pattern support a significant
species- and for E. faecalis, even a ST-based evolution ra-
ther than a high degree of HGT between these important
hospital-associated clades.
Availability of supporting data
The microarray data were deposited in the NCBI Gene
Expression Omnibus (GEO) database (http://www.ncbi.nlm.
nih.gov/geo/) under accession number GSE59190.
Consent
The strains are not original samples, but pre-selected,
diagnosed and isolated bacterial cultures and as such in-
formed consent from patients is not required. Further,
the strains were either given to the co-authors without
Material Transfer Agreement (MTA) from originating
sources, or given to the co-authours under MTA with
the permission to be used in characterization of MGEs.
Thus further consent is not necessary.
Additional files
Additional file 1: Table S1. Correlation matrix for quantile normalized
technical replicate (E. faecalis V583). Each fourplex microarray slide
included the control strain, E. faecalis V583 to monitor the correlation
between the hybridizations and to produce an appropriate cut off value.
The overall correlation between the hybridization was 0.95, producing
less than 1/20 false positive hybridizations. The grey rows and columns
indicate (number of slide)_(sector on slide)_(number of hybridizations of
slide) representing each sector hybridized with genomic DNA of E.
faecalis V583.
Additional file 2: Figure S1. A: PCA of the mobilome in 41
enterococcal strains. Each dot represents one of the 41 strains projected
by their overall hybridization profile. E. faecium ST17 and ST78 strains are
represented by blue and orange, respectively, E. faecalis ST6 and ST40
strains by red and green, respectively, while E. faecium ST92 is marked in
purple. Strains are numbered as in Table 1. Each repeated hybridization
of control strain E. faecalis V583 is represented by a black spot, B: Cluster
dendrogram of the mobilome in 41 enterococcal strains. The
dendrogram is visualizing the result of a hierarchical clustering
calculation of the mobilome. Strains are numbered as in Table 1, and
every application of the control strains E. faecalis V583 is indicated by a ‘C’.
Additional file 3: Figure S2. Gene profile of the 40 clinical
enterococcal strains. Hybridization results of 278 targets grouped into A:
plasmid backbone determinants; B: transposable elements; C: resistance
determinants; D: phage sequences; and E: CRISPR-Cas sequences in E. faecium
ST 17 (n = 10), ST78 (n = 10) and ST92 (n = 1) and E. faecalis ST6 (n = 10) and
ST40 (n = 10). Positive hybridizations are indicated by black boxes, no
hybridization by white boxes.
Additional file 4: Table S2. List of microarray targets and their
corresponding probe sequence(s). The acc.no refers to the National
Center for Biotechnology Information (NCBI) database (http://
www.ncbi.nlm.nih.gov/), and the target names correspond to the locus
names annotated in GenBank. Each target is represented by 1–5 probes
in the DNA array as indicated.
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Additional file 5: Figure S3. Summarized gene profile of four
enterococcal STs. Number of positive E. faecium ST17 (n = 10) and ST78
(n = 10) and E. faecalis ST6 (n = 10) and ST40 (n = 10) for selected targets
within five groups; A: plasmid replicons and plasmid addiction systems; B:
transposable elements; C: resistance determinants; D: phage; and E:
CRISPR-Cas, determined by DNA microarray. Detailed information of each
microarray target is found in Additional file 4: Table S2. Note that the
presence of pIP501 repR, pCF10 prgW, pLG1 rep, and aac(6’)-aph(2”)-Ia are
determined by PCR. The presence of ω-ε-ζ, vanA, vanB, and vanG genes
are also verified by PCR. Chi square (χ2) calculations are done without
corrections, and with 1 degree of freedom using the following online
calculator: http://www.graphpad.com/quickcalcs/contingency1.cfm (last
accessed December 10th, 2014). Where statistically significant differences (p <
0.05) between number of positive strains in each species (E. faecium/E. faecalis)
are indicated by light grey (of the species with most positive strains)
and between STs (ST17/78 or ST6/40) by dark grey (of the ST with
most positive strains). White boxes indicate no significant differences.
Verifying PCRs are not included in the calculations.
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